AMPK activation promotes lipid oxidation and reduces steatosis, whereas ceramide accumulation, especially from saturated fats, impairs AMPK phosphorylation, drives insulin resistance, and contributes to metabolic dysfunction (15, 16). Here, PRKAB1 is linked to steatosis.